HC Wainwright Has Positive View of Liquidia FY2027 Earnings

Liquidia Corporation (NASDAQ:LQDA) – Stock analysts at HC Wainwright increased their FY2027 earnings per share (EPS) estimates for shares of Liquidia in a report issued on Thursday, July 23rd. HC Wainwright analyst A. Fein now forecasts that the company will post earnings per share of $7.12 for the year, up from their prior forecast of $5.94. The consensus estimate for Liquidia’s current full-year earnings is $3.02 per share. HC Wainwright also issued estimates for Liquidia’s FY2028 earnings at $7.77 EPS, FY2029 earnings at $9.29 EPS and FY2030 earnings at $11.12 EPS.

A number of other brokerages have also recently issued reports on LQDA. Oppenheimer set a $75.00 price target on shares of Liquidia in a research note on Friday, June 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Liquidia in a report on Friday, July 17th. Wells Fargo & Company upped their target price on shares of Liquidia from $51.00 to $62.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 12th. Stephens set a $130.00 price target on shares of Liquidia in a report on Friday. Finally, BTIG Research raised their price target on shares of Liquidia from $59.00 to $109.00 and gave the company a “buy” rating in a research report on Monday, June 22nd. Three analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $86.18.

Liquidia Price Performance

Shares of NASDAQ:LQDA opened at $86.22 on Monday. Liquidia has a 1-year low of $16.82 and a 1-year high of $91.10. The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03. The business has a fifty day moving average price of $71.22 and a 200-day moving average price of $50.20. The company has a market capitalization of $7.67 billion, a PE ratio of 615.90 and a beta of 0.55.

Liquidia (NASDAQ:LQDA) last announced its quarterly earnings data on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The business had revenue of $132.87 million during the quarter, compared to analysts’ expectations of $119.44 million. The business’s revenue was up 4187.1% compared to the same quarter last year.

Institutional Investors Weigh In On Liquidia

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. bought a new stake in Liquidia in the 4th quarter worth approximately $25,000. Covestor Ltd raised its stake in Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after buying an additional 359 shares during the last quarter. NewEdge Advisors LLC bought a new position in shares of Liquidia during the 2nd quarter valued at $25,000. Fluent Financial LLC bought a new position in shares of Liquidia during the 2nd quarter valued at $287,000. Finally, Fulcrum Equity Management purchased a new position in shares of Liquidia in the 2nd quarter worth $399,000. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Insider Buying and Selling

In other Liquidia news, insider Sarah Krepp sold 7,864 shares of the business’s stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $71.51, for a total value of $562,354.64. Following the completion of the transaction, the insider owned 117,178 shares of the company’s stock, valued at approximately $8,379,398.78. The trade was a 6.29% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Jason Adair sold 7,863 shares of the company’s stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $71.51, for a total transaction of $562,283.13. Following the transaction, the insider owned 217,126 shares in the company, valued at $15,526,680.26. This represents a 3.49% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 2,019,870 shares of company stock worth $129,491,027 in the last three months. 25.60% of the stock is currently owned by company insiders.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).